As indicated by ROC curve analysis, the downregulation of miR-133a-3p may contribute to the upregulation of HNRNPC specifically at the BR stage, supporting the potential of miR-133a-3p as a biomarker for the BR stage of PCa. The gene discussed is HNRNPC; the disease is posterior cortical atrophy.